Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Atectura Breezhaler 125micrograms/260micrograms inhalation powder capsules with device (Novartis Pharmaceuticals UK Ltd) |
| BNF code | 0302000X0BBACAC |
| Virtual Medicinal Product | Indacaterol 125micrograms/dose / Mometasone 260micrograms/dose inhalation powder capsules with device |
| Name | Atectura Breezhaler 125micrograms/260micrograms inhalation powder capsules with device |
| Abbreviated name | Atectura Breezhaler 125microg/260microg inhalation pdr caps |
| Supplier | Novartis Pharmaceuticals UK Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Inhalation |
| Actual Medicinal Product Packs | |
| Atectura Breezhaler 125micrograms/260micrograms inhalation powder capsules with device (Novartis Pharmaceuticals UK Ltd) 30 capsule 3 x 10 capsules | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.